Australia markets closed

Kazia Therapeutics Limited (KZIA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2822+0.0012 (+0.43%)
At close: 04:00PM EDT
0.2930 +0.01 (+3.83%)
After hours: 07:11PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.76M
Enterprise value 5.61M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.22
Enterprise value/revenue -1.34k
Enterprise value/EBITDA -0.71

Trading information

Stock price history

Beta (5Y monthly) 2.05
52-week change 3-76.98%
S&P500 52-week change 326.36%
52-week high 31.3400
52-week low 30.1900
50-day moving average 30.3084
200-day moving average 30.5450

Share statistics

Avg vol (3-month) 3800.77k
Avg vol (10-day) 3142.74k
Shares outstanding 526.36M
Implied shares outstanding 623.63M
Float 8263.62M
% held by insiders 10.00%
% held by institutions 11.47%
Shares short (30 Apr 2024) 485.98k
Short ratio (30 Apr 2024) 40.03
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.33%
Shares short (prior month 28 Mar 2024) 4259.53k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 July 2017
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 314 July 2017

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-148,056,737.50%

Management effectiveness

Return on assets (ttm)-46.42%
Return on equity (ttm)-186.37%

Income statement

Revenue (ttm)560
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -17.52M
Net income avi to common (ttm)-15.7M
Diluted EPS (ttm)-0.3700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.56M
Total cash per share (mrq)0.01
Total debt (mrq)359.3k
Total debt/equity (mrq)6.82%
Current ratio (mrq)0.71
Book value per share (mrq)0.20

Cash flow statement

Operating cash flow (ttm)-12.68M
Levered free cash flow (ttm)-6.57M